Clinical Trial Update: Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension [NA]

View source ↗

Summary

The update covers the BAROSTIM NEO System trial for drug-resistant hypertension, focusing on its efficacy and safety. The study status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BAROSTIM NEO System

Snippet

Sponsor: CVRx, Inc. | Conditions: High Blood Pressure | NA | Status: ACTIVE_NOT_RECRUITING